• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes.PA28和PA700激活剂与20S蛋白酶体的同时结合。
Biochem J. 1998 Jun 15;332 ( Pt 3)(Pt 3):749-54. doi: 10.1042/bj3320749.
2
Reconstitution of hybrid proteasomes from purified PA700-20 S complexes and PA28alphabeta activator: ultrastructure and peptidase activities.从纯化的PA700-20S复合物和PA28αβ激活剂重构混合蛋白酶体:超微结构和肽酶活性
J Mol Biol. 2001 Oct 26;313(3):465-71. doi: 10.1006/jmbi.2001.5063.
3
Hybrid proteasomes. Induction by interferon-gamma and contribution to ATP-dependent proteolysis.混合蛋白酶体。由γ干扰素诱导及其对ATP依赖性蛋白水解的作用。
J Biol Chem. 2000 May 12;275(19):14336-45. doi: 10.1074/jbc.275.19.14336.
4
Tissue distribution of constitutive proteasomes, immunoproteasomes, and PA28 in rats.大鼠体内组成型蛋白酶体、免疫蛋白酶体和PA28的组织分布
Biochem Biophys Res Commun. 2000 Oct 22;277(2):348-54. doi: 10.1006/bbrc.2000.3676.
5
Regulation of proteasome complexes by gamma-interferon and phosphorylation.γ干扰素和磷酸化对蛋白酶体复合物的调控
Biochimie. 2001 Mar-Apr;83(3-4):363-6. doi: 10.1016/s0300-9084(01)01249-4.
6
Subcellular localization of proteasomes and their regulatory complexes in mammalian cells.蛋白酶体及其调节复合物在哺乳动物细胞中的亚细胞定位。
Biochem J. 2000 Feb 15;346 Pt 1(Pt 1):155-61.
7
gamma-Interferon decreases the level of 26 S proteasomes and changes the pattern of phosphorylation.γ-干扰素可降低26S蛋白酶体水平并改变磷酸化模式。
Biochem J. 2001 Jan 15;353(Pt 2):291-7. doi: 10.1042/0264-6021:3530291.
8
Regulatory proteins of the proteasome.蛋白酶体的调节蛋白。
Enzyme Protein. 1993;47(4-6):314-24. doi: 10.1159/000468689.
9
26 S proteasomes function as stable entities.26S蛋白酶体作为稳定的实体发挥作用。
J Mol Biol. 2002 Jan 25;315(4):627-36. doi: 10.1006/jmbi.2001.5285.
10
The proteasome-dependent proteolytic system.蛋白酶体依赖性蛋白水解系统。
Mol Biol Rep. 1999 Apr;26(1-2):3-9. doi: 10.1023/a:1006909522731.

引用本文的文献

1
Not Just PA28γ: What We Know About the Role of PA28αβ in Carcinogenesis.不仅仅是PA28γ:我们对PA28αβ在致癌作用中的作用的了解。
Biomolecules. 2025 Jun 16;15(6):880. doi: 10.3390/biom15060880.
2
PI31 is a positive regulator of 20S immunoproteasome assembly.PI31是20S免疫蛋白酶体组装的正向调节因子。
J Cell Sci. 2025 May 15;138(10). doi: 10.1242/jcs.263887. Epub 2025 May 23.
3
Mechanisms of ubiquitin-independent proteasomal degradation and their roles in age-related neurodegenerative disease.不依赖泛素的蛋白酶体降解机制及其在年龄相关性神经退行性疾病中的作用。
Front Cell Dev Biol. 2025 Feb 7;12:1531797. doi: 10.3389/fcell.2024.1531797. eCollection 2024.
4
PI31 is a positive regulator of 20S immunoproteasome assembly.PI31是20S免疫蛋白酶体组装的正向调节因子。
bioRxiv. 2025 Jan 15:2025.01.15.633194. doi: 10.1101/2025.01.15.633194.
5
Biologics and Non-Biologics Immunosuppressive Treatments for IgA Nephropathy in Both Adults and Children.成人和儿童IgA肾病的生物制剂和非生物制剂免疫抑制治疗
J Clin Med. 2024 Apr 23;13(9):2465. doi: 10.3390/jcm13092465.
6
Differential Interactions of the Proteasome Inhibitor PI31 with Constitutive and Immuno-20S Proteasomes.蛋白酶体抑制剂 PI31 与组成型和免疫 20S 蛋白酶体的差异相互作用。
Biochemistry. 2024 Apr 16;63(8):1000-1015. doi: 10.1021/acs.biochem.3c00707. Epub 2024 Apr 5.
7
The Functional and Mechanistic Roles of Immunoproteasome Subunits in Cancer.免疫蛋白酶体亚基在癌症中的功能和机制作用。
Cells. 2021 Dec 20;10(12):3587. doi: 10.3390/cells10123587.
8
Developing a Bimolecular Affinity Purification Strategy to Isolate 26S Proteasome Holocomplexes for Complex-Centric Proteomic Analysis.开发双分子亲和纯化策略以分离 26S 蛋白酶体全酶复合物用于以复合物为中心的蛋白质组学分析。
Anal Chem. 2021 Oct 5;93(39):13407-13413. doi: 10.1021/acs.analchem.1c03551. Epub 2021 Sep 22.
9
Proteasome activator Blm10 levels and autophagic degradation directly impact the proteasome landscape.蛋白酶体激活剂 Blm10 的水平和自噬降解直接影响蛋白酶体景观。
J Biol Chem. 2021 Jan-Jun;296:100468. doi: 10.1016/j.jbc.2021.100468. Epub 2021 Feb 25.
10
PA28γ: New Insights on an Ancient Proteasome Activator.PA28γ:古老蛋白酶体激活剂的新见解。
Biomolecules. 2021 Feb 5;11(2):228. doi: 10.3390/biom11020228.

本文引用的文献

1
Range of sizes of peptide products generated during degradation of different proteins by archaeal proteasomes.古细菌蛋白酶体降解不同蛋白质过程中产生的肽产物的大小范围。
J Biol Chem. 1998 Jan 23;273(4):1982-9. doi: 10.1074/jbc.273.4.1982.
2
Characterization of recombinant REGalpha, REGbeta, and REGgamma proteasome activators.重组REGα、REGβ和REGγ蛋白酶体激活剂的特性分析。
J Biol Chem. 1997 Oct 10;272(41):25483-92. doi: 10.1074/jbc.272.41.25483.
3
SUG1, a component of the 26 S proteasome, is an ATPase stimulated by specific RNAs.SUG1是26S蛋白酶体的一个组成部分,是一种受特定RNA刺激的ATP酶。
J Biol Chem. 1997 Sep 12;272(37):23201-5. doi: 10.1074/jbc.272.37.23201.
4
Expression and subcellular localization of mouse 20S proteasome activator complex PA28.小鼠20S蛋白酶体激活复合物PA28的表达及亚细胞定位
FEBS Lett. 1997 Aug 11;413(1):27-34. doi: 10.1016/s0014-5793(97)00864-8.
5
Production of a specific major histocompatibility complex class I-restricted epitope by ubiquitin-dependent degradation of modified ovalbumin in lymphocyte lysate.通过淋巴细胞裂解物中修饰卵清蛋白的泛素依赖性降解产生特定的主要组织相容性复合体I类限制性表位。
J Biol Chem. 1997 Aug 22;272(34):21060-6. doi: 10.1074/jbc.272.34.21060.
6
PA28 subunits of the mouse proteasome: primary structures and chromosomal localization of the genes.小鼠蛋白酶体的PA28亚基:基因的一级结构和染色体定位
Immunogenetics. 1997;46(4):337-44. doi: 10.1007/s002510050281.
7
Interferon-gamma rapidly increases peptide transporter (TAP) subunit expression and peptide transport capacity in endothelial cells.γ干扰素可迅速提高内皮细胞中肽转运体(TAP)亚基的表达及肽转运能力。
J Biol Chem. 1997 Jun 27;272(26):16585-90. doi: 10.1074/jbc.272.26.16585.
8
Molecular properties of the proteasome activator PA28 family proteins and gamma-interferon regulation.蛋白酶体激活剂PA28家族蛋白的分子特性及γ-干扰素调节
Genes Cells. 1997 Mar;2(3):195-211. doi: 10.1046/j.1365-2443.1997.d01-308.x.
9
The XPB subunit of repair/transcription factor TFIIH directly interacts with SUG1, a subunit of the 26S proteasome and putative transcription factor.修复/转录因子TFIIH的XPB亚基直接与SUG1相互作用,SUG1是26S蛋白酶体的一个亚基,也是假定的转录因子。
Nucleic Acids Res. 1997 Jun 15;25(12):2274-83. doi: 10.1093/nar/25.12.2274.
10
Proteasomes and antigen processing.蛋白酶体与抗原加工
Adv Immunol. 1997;64:1-38. doi: 10.1016/s0065-2776(08)60885-8.

PA28和PA700激活剂与20S蛋白酶体的同时结合。

Simultaneous binding of PA28 and PA700 activators to 20 S proteasomes.

作者信息

Hendil K B, Khan S, Tanaka K

机构信息

August Krogh Institute, University of Copenhagen, Universitetsparken 13, DK-2100 Copenhagen O, Denmark.

出版信息

Biochem J. 1998 Jun 15;332 ( Pt 3)(Pt 3):749-54. doi: 10.1042/bj3320749.

DOI:10.1042/bj3320749
PMID:9620878
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1219536/
Abstract

Two activators, named PA700 and PA28, are known to bind to 20 S proteasomes, forming two different complexes. The PA700-proteasome complex, also known as the 26 S proteasome, can degrade intact proteins, whereas complexes with PA28 can degrade only peptides. Monoclonal antibodies to 20 S proteasomes or the p45 ATPase subunit (Trip1, Sug1) of PA700 precipitated the same set of proteins from HeLa extracts, including six different ATPase subunits of PA700. This shows that p45 is not present in other protein complexes and suggests that all 26 S proteasome particles contain the same set of ATPase subunits. Interferons alpha and gamma had no effect on the composition of the 26 S proteasome, except for the replacement of subunits delta, MB1 and Z with Lmp2, Lmp7 and MECL1 respectively. Surprisingly, antibodies to PA28 precipitated p42, a component of PA700. Conversely, anti-p45 antibodies precipitated not only 26 S proteasomes but also PA28 alpha, beta and gamma, indicating that 20 S proteasomes can simultaneously bind both PA700 and PA28. PA28 alpha beta is known to be involved in antigen presentation. Conceivably, intact substrate proteins are recognized by PA700 and fed into proteasomes whose cleavage specificity is optimized for antigen presentation on MHC class I by PA28 and three interferon inducible proteasome subunits.

摘要

已知两种激活剂,即PA700和PA28,可与20S蛋白酶体结合,形成两种不同的复合物。PA700 - 蛋白酶体复合物,也称为26S蛋白酶体,能够降解完整蛋白质,而与PA28形成的复合物只能降解肽段。针对20S蛋白酶体或PA700的p45 ATP酶亚基(Trip1、Sug1)的单克隆抗体,从HeLa细胞提取物中沉淀出同一组蛋白质,包括PA700的六种不同ATP酶亚基。这表明p45不存在于其他蛋白质复合物中,并提示所有26S蛋白酶体颗粒都含有相同的ATP酶亚基。α干扰素和γ干扰素对26S蛋白酶体的组成没有影响,只是分别用Lmp2、Lmp7和MECL1取代了δ、MB1和Z亚基。令人惊讶的是,针对PA28的抗体沉淀出了PA700的一个组分p42。相反,抗p45抗体不仅沉淀出26S蛋白酶体,还沉淀出PA28α、β和γ,表明20S蛋白酶体可同时结合PA700和PA28。已知PA28αβ参与抗原呈递。可以想象,完整的底物蛋白被PA700识别并送入蛋白酶体,其切割特异性通过PA28和三个干扰素诱导的蛋白酶体亚基针对MHC I类分子上的抗原呈递进行了优化。